|
Refractec was founded in 1993 to develop and market proprietary technology that would help baby boomers improve their near vision. The result is NearVisionSM CK® a safe, non-laser vision-correction procedure that is allowing patients to end their frustration with reading glasses. Using the first FDA-approved technology for patients who are presbyopic and hyperopic, physicians have performed over 150,000 treatments, and in the process, are helping patients "see young, again." |